Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location |
|---|---|---|---|
Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria |
Uncomplicated Plasmodium Falciparum Malaria | Phase 2 | Burkina Faso Mali Gabon |
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis |
Multiple Sclerosis | Phase 4 | Taiwan |
Study of Safety, Tolerability and Clinical Outcomes of Egaten in Fascioliasis Patients (6 Years of Age or Older). |
Fascioliasis | Phase 4 | Egypt Peru Colombia Vietnam View All |
Study of Out of Specification for Tisagenlecleucel |
B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma | Phase 3 | Japan |
Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments |
Advanced Solid Tumors | Phase 1 | United States Czech Republic Hungary Germany China Hong Kong Belgium Spain Canada Italy Korea, Republic of Taiwan Switzerland View All |
Pediatric Long-Term Follow-up and Rollover Study |
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood, Anaplastic Oligodendroglioma, Glioblastoma, Pilocytic Astrocytoma, Giant Cell Astrocytoma, Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, Angiocentric Glioma, Chordoid Glioma of Third Ventricle, Gangliocytoma, Ganglioglioma, Anaplastic Ganglioglioma, Dysplastic Gangliocytoma of Cerebrellum, Desmoplastic Infantile Astrocytoma and Ganglioglioma, Papillary Glioneuronal Tumor, Rosette-forming Glioneurona Tumor, Central Neurocytoma, Extraventricular Neurocytoma, Cerebellar Liponeurocytoma, Neurofibromatosis Type 1 | Phase 4 | United States United Kingdom Brazil |
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, ALL and 1L HR LBCL |
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Large B-cell Lymphoma | Phase 1, Phase 2 | United States Spain Italy Japan Germany France Australia Austria View All |
Long-term Efficacy, Safety and Tolerability of LNP023 in C3G |
C3 Glomerulopathy | Phase 3 | Turkey Japan China Switzerland Argentina Germany Greece United States Netherlands United Kingdom Spain France Israel Italy Brazil View All |
Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients |
B-Cell Acute Lymphoblastic Leukemia | Phase 2 | United States Spain Belgium United Kingdom Italy Norway France Sweden Netherlands View All |
Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa |
Hidradenitis Suppurativa | Phase 2 | United States France Spain Germany Belgium Hungary Austria View All |